Delenex Therapeutics' Acquisition

Delenex Therapeutics was acquired by Cell Medica on July 12, 2016.

Delenex is a biopharmaceutical company focused on the development of locally or topically applied antibody therapeutics. Thereby Delenex aims at extending the benefits of proven antibody therapeutics …

Articles about Delenex Therapeutics' Acquisition: